Treatment of Cardiac Hemochromatosis
Journal Title: Heart Research – Open Journal - Year 2015, Vol 2, Issue 3
Abstract
Treatment of iron-overload states is important to prevent or reverse cardiac dysfunction.1-5 Removal of excess iron from the tissues in these patients reduces generation of free radicals, decreasing organ damage.6,7 Removal of excess iron stores includes therapeutic phlebotomy and iron-chelating agents. Management of the disease causing iron overload and dietary management are also important in treating cardiac hemochromatosis. Dietary management includes avoidance of medicinal iron, mineral supplements, excess vitamin C, and uncooked seafoods.5 Congestive heart failure should be treated with guideline-directed medical therapy for heart failure.8
Authors and Affiliations
Wilbert S. Aronow
Keywords
Related Articles
- EP ID EP556890
- DOI 10.17140/HROJ-2-e002
- Views 106
- Downloads 0
Impact of Resistance Training on Quality of Life and Ischemia Modified Albumin Levels in Men with Cardiovascular Risk Factors
Purpose: There are limited data concerning the effects of Resistance Training (RT) on the components of Quality of Life (QOL) and Ischemia Modified Albumin (IMA) serum levels, even though QOL is an important characterist...
E-Care Project: A Promising E-Platform for Optimizing Management of Chronic Heart Failure and Other Chronic Diseases
Monitoring patients with heart failure by using telemedicine systems is a potential means for optimizing the management of these patients. The E-care project is developing an “intelligent” communicative platform enabling...
Carcinoid Heart Disease and Review of Literature
Carcinoid Heart Disease (CHD) is one of the rare causes of acquired valvular heart disease. CHD develops as a systemic manifestation of metastatic neuroendocrine tumors (NETs). When these tumors metastasize to the liver,...
Writing Thank You Notes after Ophthalmology Residency Interviews?
Objective: To determine the importance of writing thank you notes after ophthalmology residency interviews. Design: Survey. Participants: Ophthalmology residency faculty members. Methods: A short multiple-choice survey u...
Combination Therapy With Beta Blocker and Inotrope in Decompensated Heart Failure: A Clinical Observation
Inotropic support is contemplated in the presence of ongoing end-organ hypoperfusion or refractory symptoms in decompensated heart failure (DHF). However, inotropic agents may cause tachycardia leading to increased myoca...